Price $34.72 |
Market Cap
1.48B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.19
|
P/S
5.43
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-900
|
FCF
-0.1
|
|
Op. Margin
-4.60%
|
Net Margin
-5.20%
|
ROE
-5.00%
|
ROI
-4.20%
|
|
ROA
-3.90%
|
EPS Growth
56.20%
|
Current Ratio
5.2
|
Debt/Equity
7.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Inogen Inc (INGN) | $46.75 | - | - | 1.36B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.68 | - | - | 10.34B | Strong Buy |
| Bausch Health Companies Inc (BHC) | $28.21 | - | - | 10.56B | Strong Buy |
| Sensus Healthcare Inc (SRTS) | $3.54 | - | - | 60.2M | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.71 | - | - | 709M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
